AI Startup Simile Raises $200 Million in Series B Funding, Valued at $2 Billion

AI startup Simile has completed a $200 million Series B funding round at a valuation of $2 billion. The round was led by Greenoaks, with participation from Index Ventures, Hanabi, Bain Capital Ventures, A*, Factory, Definition, and CVS Health Ventures. This funding comes just five months after Simile raised $100 million in Series A funding, with CVS Health Ventures also being a major client of Simile. Founded by Stanford PhD Joon Sung Park, Simile's doctoral project "Smallville" aims to enable AI agents to simulate human life, with the goal of "accurately and honestly simulating all 8 billion people on Earth" to facilitate marketing and product research through user simulation.

This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.